// App-Quantinova.ai

2437 : Trends in Allogeneic Stem Cell Transplantation for Myelofibrosis in Europe between 1995-2018: An EBMT Retrospective Analysis

Researchers

Presenter

  • Donal P. McLornan

Principal Investigators

  • Nicolaus Krger

  • Linda Koster

  • Tomasz Czerw

  • Dietrich W. Beelen

  • Emanuele Angelucci

  • Marie Robin

  • Martin Bornhaeuser

  • Jakob Passweg

  • Grant McQuaker

  • Antonin Vitek

  • Jrgen Finke Sr

  • Igor W Blau

  • Riitta Niittyvuopio

  • Uwe Platzbecker

  • Jan J. Cornelissen

  • Patrice Chevallier

  • Micha Srour

  • Dragana Stamatovic

  • Joaqun Martnez-Lopez

  • Liesbeth C. de Wreede

  • Patrick J Hayden

  • Juan Carlos Hernandez Boluda

  • Ibrahim Yakoub-Agha

Medical Centers

  • Department of Medical Oncology, Guys and St Thomas NHS Foundation Trust, London, United Kingdom

  • Department of Medical Statistics, Leiden University Medical Center, Leiden, Netherlands

  • Department for stem cell transplantation, University Hospital, Hamburg, Germany

  • EBMT Data Office Leiden, Department of Medical Statistics and Bioinformatics, Leiden University Medical Center, Leiden, Netherlands

  • Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology Gliwice Branch, Gliwice, Poland

  • Department of Stem Cell Transplantation, University of Essen, Essen, Germany,

  • Hematology and transplant center,IRCCS Ospedale Policlinico San Martino,Genova,Italy

  • SBIM, Hopital Saint-Louis, APHP, Paris, France

  • Universitatsklinikum Cad GustavCarus an der Technischen Universltat Dresden, Dresden, Ferscherstrabo 74, Germany

  • Haematology, University Hospital, Basel, Switzerland

  • The Beatson, West of Scotland Cancer Centre, Glasgow,

  • Hematology Service, Institute of Hematology and Blood Transfusion, Prague, Czech Republic, PRAGUE, Czech Republic

  • University of Freiburg, Freiburg, Germany, Dept. of Hematology, Oncology and Stem Cell Transplantation,, Freiburg, Germany

  • Charite - Universitatsmedizin Berlin, Hematology/Oncology/Tumorimmunology, Berlin, Germany

  • Helsinki Hospital, HELSINKI, FIN

  • Dept. Hematology and Cell Therapy,University Hospital Leipzig,Leipzig,Germania

  • Department of Hematology, Erasmus MC Cancer Insitute, Rotterdam, Netherlands

  • Hematology Clinic, CHU Nantes, Nantes, France

  • Military Medical Academy, Belgrade, Serbia

  • Department of Hematology, Hospital 12 de Octubre, Complutense University, H12O-CNIO Clinical Research Unit, CIBERONC, Madrid, Spain

  • LUMC, Dept. Medical Statistics & Bioinformatics, Leiden, Netherlands

  • Department of Histopathology, St. James's Hospital, Dublin, Ireland

  • Hospital Clínico Universitario,VALLADOLID,Spain

  • Univ Lille, CHU de Lille, INFINITE, INSERM U1286, 59000 Lille, LILLE, France

Locations

  • United Kingdom

  • Netherlands

  • Germany

  • Poland

  • Italy

  • France

  • Switzerland

  • Czech Republic

  • Spain

  • Ireland

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Essential thrombocythemia

  • Polycythaemia vera

  • Myelofibrosis

  • Graft-versus-host disease

Biomarkers

  • N/A

Drug/Treatment

  • Busulfex

  • Allopurinol

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved